What top creators are saying about Innovent Biologics Inc.(1801)
A Suzhou-based Chinese biopharmaceutical company developing a GLP-1 drug called Mazdatide.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Innovent Biologics Inc. in the last 30 days yet.
Top creators covering Innovent Biologics Inc. (1801)
The 1 sources with the most insights about Innovent Biologics Inc. on Kazuha.
Latest insights about Innovent Biologics Inc. (1801)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Tuesday, January 13, 2026
Positioned to capture a large share of the booming domestic Chinese market for weight loss drugs and has the potential to become a major global player in the space.
Tuesday, January 13, 2026
Positioned to capture a large share of the booming domestic Chinese market for weight loss drugs and has the potential to become a major global player in the space.
Discussed alongside Innovent Biologics Inc. (1801)
Other assets that creators frequently mention in the same content as Innovent Biologics Inc..
Frequently asked
Which podcasters and creators cover Innovent Biologics Inc. (1801) the most?
The most active sources covering Innovent Biologics Inc. (1801) on Kazuha are @theprofgpod. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Innovent Biologics Inc. (1801) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Innovent Biologics Inc. (1801) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Innovent Biologics Inc. (1801)?
Creators covering Innovent Biologics Inc. (1801) most frequently also discuss JD, 3690, HG, BABA, 000963. See the "Discussed alongside" section above for full asset pages.